Accès gratuit
Méd. Intensive Réa.
Volume 26, Numéro 5, Septembre 2017
Neuroréanimation et toxicologie
Page(s) 383 - 395
Section Mise au point / Update
Publié en ligne 1 septembre 2017
  • Mowry JB, Spyker DA, Brooks DE, Zimmerman A, Schauben JL, (2016) 2015 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 33rd Annual Report. Clin Toxicol (Phila) 54: 924–1109 [CrossRef] [PubMed] [Google Scholar]
  • Legout C, Villa A, Baud F, Baffert E, Eftekhari P, Langrand J, Robin A, Alvarez JC, Blanc I, Deveaux M, Aegerter P, Galichon B, Castot-Villepelet A, Garnier R, (2015) Observatoire multisources des intoxications aiguës en Île-de-France : une étude exploratoire. BEH 32–33: 579–585. [Google Scholar]
  • Linden CH, Rumack BH, (1984) Acetaminophen overdose. Emerg Med Clin North Am 2: 103–119 [PubMed] [Google Scholar]
  • Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, Reisch JS, Schiødt FV, Ostapowicz G, Shakil AO, Lee WM; Acute Liver Failure Study Group, (2005) Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 42: 1364–1372 [CrossRef] [PubMed] [Google Scholar]
  • Forrest JA, Clements JA, Prescott LF, (1982) Clinical pharmacokinetics of paracetamol. Clin Pharmacokinet 7: 93–107 [CrossRef] [PubMed] [Google Scholar]
  • Lancaster EM, Hiatt JR, Zarrinpar A, (2015) Acetaminophen hepatotoxicity: an updated review. Arch Toxicol 89: 193–199 [CrossRef] [PubMed] [Google Scholar]
  • Wong A, Graudins A, (2017) Risk prediction of hepatotoxicity in paracetamol poisoning. Clin Toxicol (Phila) 27: 1–14 [Google Scholar]
  • Suzuki A, Yuen N, Walsh J, Papay J, Hunt CM, Diehl AM, (2009) Co-medications that modulate liver injury and repair influence clinical outcome of acetaminophen-associated liver injury. Clin Gastroenterol Hepatol 7: 882–888 [CrossRef] [PubMed] [Google Scholar]
  • Michaut A, Moreau C, Robin MA, Fromenty B, (2014) Acetaminophen-induced liver injury in obesity and nonalcoholic fatty liver disease. Liver Int 34: e171–e179. [CrossRef] [Google Scholar]
  • Possamai LA, McPhail MJ, Khamri W, Wu B, Concas D, Harrison M, Williams R, Cox RD, Cox IJ, Anstee QM, Thursz MR, (2015) The role of intestinal microbiota in murine models of acetaminophen-induced hepatotoxicity. Liver Int 35: 764–773 [CrossRef] [Google Scholar]
  • Shah AD, Wood DM, Dargan PIES, (2011) Understanding lactic acidosis in paracetamol (acetaminophen) poisoning. Br J Clin Pharmacol 71: 20–28 [CrossRef] [PubMed] [Google Scholar]
  • Gosselin S, Juurlink DN, Kielstein JT, Ghannoum M, Lavergne V, Nolin TD, Hoffman RS; Extrip Workgroup, (2014) Extracorporeal treatment for acetaminophen poisoning: recommendations from the EXTRIP workgroup. Clin Toxicol (Phila) 52: 856–867 [CrossRef] [PubMed] [Google Scholar]
  • Hernandez SH, Howland M, Schiano TD, Hoffman RS, (2015) The pharmacokinetics and extracorporeal removal of N-acetylcysteine during renal replacement therapies. Clin Toxicol (Phila) 53: 941–949 [CrossRef] [PubMed] [Google Scholar]
  • Buckley NA, Whyte IM, O'Connell DL, Dawson AH, (1999) Activated charcoal reduces the need for N-acetylcysteine treatment after acetaminophen (paracetamol) overdose. J Toxicol Clin Toxicol 37: 753–757 [CrossRef] [PubMed] [Google Scholar]
  • Mégarbane B, Donetti L, Blanc T, Jacobs F, Groupe d’experts de la SRLF, (2006) Intoxications graves par médicaments et substances illicites en réanimation. Réanimation 15: 332–342 [CrossRef] [Google Scholar]
  • Prescott LF, Roscoe P, Wright N, Brown SS, (1971) Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet 1: 519–522 [CrossRef] [PubMed] [Google Scholar]
  • Rumack BH, Matthew H, (1975) Acetaminophen poisoning and toxicity. Pediatrics 55: 871–876 [PubMed] [Google Scholar]
  • Rumack BH, Peterson RC, Koch GG, Amara IA, (1981) Acetaminophen overdose: 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med 141: 380–385 [CrossRef] [PubMed] [Google Scholar]
  • Schiødt FV, Rochling FA, Casey DL, Lee WM, (1997) Acetaminophen toxicity in an urban county hospital. N Engl J Med 337: 1112–1117 [CrossRef] [PubMed] [Google Scholar]
  • Craig DG, Bates CM, Davidson JS, Martin KG, Hayes PC, Simpson KJ, (2012) Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity. Br J Clin Pharmacol 73: 285–294 [CrossRef] [PubMed] [Google Scholar]
  • Medicines and Healthcare Products Regulatory Agency (2012) Benefit risk profile of acetylcysteine in the management of paracetamol overdose. [Google Scholar]
  • Bateman DN, Carroll R, Pettie J, Yamamoto T, Elamin ME, Peart L, Dow M, Coyle J, Cranfield KR, Hook C, Sandilands EA, Veiraiah A, Webb D, Gray A, Dargan PI, Wood DM, Thomas SH, Dear JW, Eddleston M, (2014) Effect of the UK’s revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment. Br J Clin Pharmacol 78: 610–618 [CrossRef] [PubMed] [Google Scholar]
  • Villeneuve E, Gosselin S, Whyte I, (2014) Four-hour acetaminophen concentration estimation after ingested dose based on pharmacokinetic models. Clin Toxicol (Phila) 52: 556–560 [CrossRef] [PubMed] [Google Scholar]
  • Wong A, Sivilotti ML, Dargan PI, Wood DM, Greene SL, (2015) External validation of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity from paracetamol overdose. Clin Toxicol (Phila) 53: 807–814 [CrossRef] [PubMed] [Google Scholar]
  • Chomchai S, Chomchai C, (2014) Predicting acute acetaminophen hepatotoxicity with acetaminophen-aminotransferase multiplication product and the Psi parameter. Clin Toxicol (Phila) 52: 506–511 [CrossRef] [PubMed] [Google Scholar]
  • Beger RD, Bhattacharyya S, Yang X, Gill PS, Schnackenberg LK, Sun J, James LP, (2015) Translational biomarkers of acetaminophen-induced acute liver injury. Arch Toxicol 89: 1497–1522 [CrossRef] [PubMed] [Google Scholar]
  • Antoine DJ, Sabbisetti VS, Francis B, Jorgensen AL, Craig DG, Simpson KJ, Bonventre JV, Park BK, Dear JW, (2013) Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology 58: 777–787 [CrossRef] [PubMed] [Google Scholar]
  • Vliegenthart AD, Shaffer JM, Clarke JI, Peeters LE, Caporali A, Bateman DN, Wood DM, Dargan PI, Craig DG, Moore JK, Thompson AI, Henderson NC, Webb DJ, Sharkey J, Antoine DJ, Park BK, Bailey MA, Lader E, Simpson KJ, Dear JW, (2015) Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury. Sci Rep 5: 15501 [CrossRef] [PubMed] [Google Scholar]
  • Vliegenthart A, Kimmitt RA, Seymour JH, Homer NZ, Clarke JI, Eddleston M, Gray A, Wood DM, Dargan PI, Cooper JG, Antoine DJ, Webb DJ, Lewis SC, Bateman DN, Dear JW, (2017) Circulating acetaminophen metabolites are toxicokinetic biomarkers of acute liver injury. Clin Pharmacol Ther 101: 531–540 [CrossRef] [PubMed] [Google Scholar]
  • Vliegenthart AD, Antoine DJ, Dear JW, (2015) Target biomarker profile for the clinical management of paracetamol overdose. Br J Clin Pharmacol 80: 351–362 [CrossRef] [Google Scholar]
  • James LP, Letzig L, Simpson PM, Capparelli E, Roberts DW, Hinson JA, Davern TJ, Lee WM, (2009) Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure. Drug Metab Dispos 37: 1779–1784 [CrossRef] [PubMed] [Google Scholar]
  • Possamai LA, McPhail MJ, Quaglia A, Zingarelli V, Abeles RD, Tidswell R, Puthucheary Z, Rawal J, Karvellas CJ, Leslie EM, Hughes RD, Ma Y, Jassem W, Shawcross DL, Bernal W, Dharwan A, Heaton ND, Thursz M, Wendon JA, Mitry RR, Antoniades CG, (2013) Character and temporal evolution of apoptosis in acetaminophen-induced acute liver failure. Crit Care Med 41: 2543–2550 [CrossRef] [PubMed] [Google Scholar]
  • Heard KJ, (2008) Acetylcysteine for acetaminophen poisoning. N Engl J Med 359: 285–292 [CrossRef] [PubMed] [Google Scholar]
  • Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT, (1979) Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. Br Med J 2: 1097–1100 [CrossRef] [PubMed] [Google Scholar]
  • Kerr F, Dawson A, Whyte IM, Buckley N, Murray L, Graudins A, Chan B, Trudinger B, (2005) The Australasian Clinical Toxicology Investigators Collaboration randomized trial of different loading infusion rates of N-acetylcysteine. Ann Emerg Med 45: 402–408 [CrossRef] [PubMed] [Google Scholar]
  • Waring WS, Stephen AF, Robinson OD, Dow MA, Pettie JM, (2008) Lower incidence of anaphylactoid reactions to N-acetylcysteine in patients with high acetaminophen concentrations after overdose. Clin Toxicol (Phila) 46: 496–500 [CrossRef] [PubMed] [Google Scholar]
  • Coulson J, Thompson JP, (2010) Paracetamol (acetaminophen) attenuates in vitro mast cell and peripheral blood mononucleocyte cell histamine release induced by N-acetylcysteine. Clin Toxicol (Phila) 48: 111–114 [CrossRef] [PubMed] [Google Scholar]
  • Mégarbane B, Deye N, Baud FJ, (2008) Acetaminophen poisoning. N Engl J Med 359: 1962–1963 [CrossRef] [PubMed] [Google Scholar]
  • Hayes BD, Klein-Schwartz W, Doyon S, (2008) Frequency of medication errors with intravenous acetylcysteine for acetaminophen overdose. Ann Pharmacother 42: 766–770 [CrossRef] [PubMed] [Google Scholar]
  • Chiew AL, Isbister GK, Duffull SB, Buckley NA, (2016) Evidence for the changing regimens of acetylcysteine. Br J Clin Pharmacol 81: 471–481 [CrossRef] [Google Scholar]
  • Bateman DN, Dear JW, Thanacoody HK, Thomas SH, Eddleston M, Sandilands EA, Coyle J, Cooper JG, Rodriguez A, Butcher I, Lewis SC, Vliegenthart AD, Veiraiah A, Webb DJ, Gray A, (2014) Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial. Lancet 383: 697–704 [CrossRef] [PubMed] [Google Scholar]
  • Wong A, Graudins A, (2016) Simplification of the standard three-bag intravenous acetylcysteine regimen for paracetamol poisoning results in a lower incidence of adverse drug reactions. Clin Toxicol (Phila) 54: 115–119 [CrossRef] [PubMed] [Google Scholar]
  • Isbister GK, Downes MA, Mcnamara K, Berling I, Whyte IM, Page CB, (2016) A prospective observational study of a novel 2-phase infusion protocol for the administration of acetylcysteine in paracetamol poisoning. Clin Toxicol (Phila) 54: 120–126 [CrossRef] [PubMed] [Google Scholar]
  • Chiew AL, Isbister GK, Kirby KA, Page CB, Chan BSH, Buckley NA, (2017) Massive paracetamol overdose: an observational study of the effect of activated charcoal and increased acetylcysteine dose (ATOM-2). Clin Toxicol (Phila) 23: 1–11 [CrossRef] [Google Scholar]
  • Lucyk SN, Yarema MC, Sivilotti ML, Johnson DW, Nettel-Aguirre A, Victorino C, Bailey B, Dart RC, Heard K, Spyker DA, Rumack BH, (2016) Outcomes of patients with premature discontinuation of the 21-h intravenous N-acetylcysteine protocol after acute acetaminophen overdose. J Emerg Med 50: 629–637 [CrossRef] [PubMed] [Google Scholar]
  • American College of Medical Toxicology, (2017) ACMT Position statement: duration of intravenous acetylcysteine therapy following acetaminophen overdose. J Med Toxicol 13: 126–127 [CrossRef] [PubMed] [Google Scholar]
  • Curtis RM, Sivilotti ML, (2015) A descriptive analysis of aspartate and alanine-aminotransferase rise and fall following acetaminophen overdose. Clin Toxicol (Phila) 53: 849–855 [CrossRef] [PubMed] [Google Scholar]
  • McGovern AJ, Vitkovitsky IV, Jones DL, Mullins ME, (2015) Can AST/ALT ratio indicate recovery after acute paracetamol poisoning? Clin Toxicol (Phila) 53: 164–167 [CrossRef] [PubMed] [Google Scholar]
  • Roberts DM, Buckley NA, (2008) Prolonged absorption and delayed peak paracetamol concentration following poisoning with extended-release formulation. Med J Aust 188: 310–311 [PubMed] [Google Scholar]
  • Owumi SE, Andrus JP, Herzenberg LA, Herzenberg LA, (2015) Co-administration of N-acetylcysteine and acetaminophen efficiently blocks acetaminophen toxicity. Drug Dev Res 76: 251–258 [CrossRef] [PubMed] [Google Scholar]
  • Ostapowicz G, Fontana RJ, Schiødt FV, Larson A, Davern TJ, Han SH, McCashland TM, Shakil AO, Hay JE, Hynan L, Crippin JS, Blei AT, Samuel G, Reisch J, Lee WM; US Acute Liver Failure Study Group, (2002) Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137: 947–954 [CrossRef] [PubMed] [Google Scholar]
  • Simpson KJ, Bates CM, Henderson NC, Wigmore SJ, Garden OJ, Lee A, Pollok A, Masterton G, Hayes PC, (2009) The utilization of liver transplantation in the management of acute liver failure: comparison between acetaminophen and non-acetaminophen etiologies. Liver Transpl 15: 600–609 [CrossRef] [PubMed] [Google Scholar]
  • Craig DG, Lee A, Hayes PC, Simpson KJ, (2010) Review article: the current management of acute liver failure. Aliment Pharmacol Ther 31: 345–358 [CrossRef] [Google Scholar]
  • Craig DG, Ford AC, Hayes PC, Simpson KJ, (2010) Systematic review: prognostic tests of paracetamol-induced acute liver failure. Aliment Pharmacol Ther 31: 1064–1076 [CrossRef] [Google Scholar]
  • O'Grady JG, Alexander GJ, Hayllar KM, Williams R, (1989) Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97: 439–445 [CrossRef] [Google Scholar]
  • Bernal W, Wang Y, Maggs J, Willars C, Sizer E, Auzinger G, Murphy N, Harding D, Elsharkawy A, Simpson K, Larsen FS, Heaton N, O'Grady J, Williams R, Wendon J, (2016) Development and validation of a dynamic outcome prediction model for paracetamol-induced acute liver failure: a cohort study. Lancet Gastroenterol Hepatol 1: 217–225 [CrossRef] [PubMed] [Google Scholar]
  • Bernuau J, Goudeau A, Poynard T, Dubois F, Lesage G, Yvonnet B, Degott C, Bezeaud A, Rueff B, Benhamou JP, (1986) Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 6: 648–651 [CrossRef] [PubMed] [Google Scholar]
  • O’Grady J, (2012) Liver transplantation for acute liver failure. Best Pract Res Clin Gastroenterol 26: 27–33 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.